VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
INTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
INTSIntensity Therapeutics, Inc.
$4.78$121M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksINTSQuarterly Financials

Intensity Therapeutics, Inc. (INTS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Intensity Therapeutics, Inc. (INTS) quarterly income statement — complete revenue, gross profit & net income history

INTS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q1'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold7K00000006K0038.62K100.47K0000000
COGS % of Revenue--------------------
Gross Profit-7K0000000-6K00-38.62K-100.47K0000000
Gross Margin %--------------------
Gross Profit Growth %----100%--100%94.03%-----------
Operating Expenses2.53M3.14M2.73M2.71M3.39M3.2M3.57M5.07M4.74M3.35M2.49M1.18M1.15M1.56M1.77M1.93M2.38M2.41M2.14M1.5M
OpEx % of Revenue--------------------
Selling, General & Admin1.33M1.64M1.18M1.16M1.21M1.24M1.42M1.51M1.92M1.55M1.14M323.87K379.88K584.03K607.11K543.83K684K972.67K639.46K284.04K
SG&A % of Revenue--------------------
Research & Development1.2M1.5M1.55M1.54M2.19M1.97M2.15M3.56M2.81M1.8M1.35M859.21K773.77K891.11K1.16M1.39M1.69M1.44M1.5M1.22M
R&D % of Revenue--------------------
Other Operating Expenses000000000000080.71K0023000
Operating Income-2.53M-3.14M-2.73M-2.71M-3.39M-3.2M-3.57M-5.07M-4.74M-3.35M-2.49M-1.22M-1.25M-1.56M-1.77M-1.93M-2.38M-2.41M-2.14M-1.5M
Operating Margin %--------------------
Operating Income Growth %25.57%1.97%23.45%46.64%28.44%4.46%-43.32%-314.91%-278.19%-115.49%-40.91%36.69%47.27%35.45%17.31%--58.47%-45.43%--
EBITDA-2.53M-3.14M0-2.71M-3.39M-3.18M-3.51M-5.07M-4.74M-3.17M-2.33M-1.18M-1.15M-1.47M-1.76M-1.89M-2.33M-2.41M-2.14M-1.5M
EBITDA Margin %--------------------
EBITDA Growth %25.57%1.29%100%46.64%28.35%-0.3%-50.84%-328.46%-310.61%-115.08%-32.35%37.25%50.58%38.82%17.69%--55.53%-50.44%--
D&A (Non-Cash Add-back)002.73M000006K0038.62K100.47K0044.53K44.09K000
EBIT-2.53M-3.14M-2.67M-2.71M-3.39M-3.18M-3.51M-5.07M-4.6M-3.17M-2.33M-3.48M-1.25M-1.47M-1.76M-1.91M-2.35M-2.41M-2.14M-1.5M
Net Interest Income94K88K59K17K15K28K48K98K140K175.97K147.54K-222K-83K-36.27K-14.13K-14.75K-14.15K348647739
Interest Income94K88K59K17K15K28K48K98K140K175.97K147.54K171316637988213643348647739
Interest Expense00000000000221.78K83.38K36.9K15.12K14.96K14.79K000
Other Income/Expense92K89K62K168K47K22K57K98K140K181.41K162K-2.48M-82.11K44.45K-7.02K2.15K9.5K9.13K13.18K22.07K
Pretax Income-2.43M-3.05M-2.67M-2.54M-3.35M-3.18M-3.51M-4.97M-4.6M-3.17M-2.33M-3.7M-1.34M-1.51M-1.77M-1.93M-2.37M-2.4M-2.12M-1.48M
Pretax Margin %--------------------
Income Tax0000000000003560000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%-0.03%0%0%0%0%0%0%0%
Net Income-2.43M-3.05M-2.67M-2.54M-3.35M-3.18M-3.51M-4.97M-4.6M-3.17M-2.33M-3.7M-1.34M-1.51M-1.77M-1.93M-2.37M-2.4M-2.12M-1.48M
Net Margin %--------------------
Net Income Growth %27.28%4.09%23.97%48.96%27.29%-0.31%-50.84%-34.33%-244.41%-109.97%-31.22%-91.97%43.59%37.1%16.46%--60.2%-46.9%--
Net Income (Continuing)-2.43M-3.05M-2.67M-2.54M-3.35M-3.18M-3.51M-4.97M-4.6M-3.17M-2.33M-3.7M-1.34M-1.51M-1.77M-1.93M-2.37M-2.4M-2.12M-1.48M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.96-1.21-1.55-3.25-5.50-5.50-6.25-9.00-8.50-5.75-4.25-35.75-9.75-11.00-13.00-14.25-17.25-17.50-15.50-10.75
EPS Growth %82.55%78%75.2%63.89%35.29%4.35%-47.06%74.83%12.82%47.73%67.31%-150.88%43.48%37.14%16.13%--60.47%-45.83%--
EPS (Basic)-0.96-1.21-1.55-3.25-5.50-5.50-6.25-9.00-8.50-5.75-4.25-35.75-9.75-11.00-13.00-14.25-17.25-17.50-15.50-10.75
Diluted Shares Outstanding25.34M13.56M1.72M754.73K606.93K576.04K552.19K548.49K548.38K550.61K546.42K140.66K136.4K136.4K136.4K136.4K136.4K136.4K136.4K136.4K
Basic Shares Outstanding25.34M13.56M1.72M754.72K606.92K576K552.16K548.48K548.36K550.6K546.4K103.6K136.4K136.4K136.4K136.4K136.4K136.4K136.4K136.4K
Dividend Payout Ratio--------------------